The number of US consumers falsely convinced from self-diagnosis that they have COVID-19 likely will fall and a California medtech firm’s business outlook should improve with sales authorized for the first test providing at-home results including differentiating the flu from the novel coronavirus.
The emergency use authorization the Food and Drug Administration announced on 24 February for Lucira Health Inc.’s COVID-19 & Flu...